---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-029517"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2026-06-22T13:05:10+00:00"
generated_at: "2026-06-22T13:06:13.468914+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INVO Fertility Q1 revenue up 23% to $2.0M; net loss widens on warrant charge, balance sheet strengthened

## Summary
- Revenue $2.02M (+23% YoY); clinic revenue $1.98M (+22%) driven by organic growth and Family Beginnings acquisition.
- Net loss from continuing ops $5.5M (incl. $3.8M non-cash warrant remeasurement) vs $1.5M prior year.
- Adjusted EBITDA -$1.26M vs -$0.6M; investments in personnel and infrastructure for future clinic expansion.
- Eliminated all Series C-2 Preferred ($2.4M) and warrant liabilities ($1.9M); cash rose to $4.9M from $2.1M at Dec 2025.
- Stockholders' equity more than doubled to $15.0M (108% increase); total liabilities down 26% to $9.6M.

## SEC filing metadata
- accession: 0001493152-26-029517
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2026-06-22T13:05:10+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315226029517/0001493152-26-029517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315226029517/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-029517
- JSON: https://secwatch.observer/filing/0001493152-26-029517.json
- Plain text: https://secwatch.observer/filing/0001493152-26-029517.txt

## Key facts
- Earnings Releases
  INVO Fertility, Inc. reported first quarter ended March 31, 2026 results: revenue $2,015,225, net income $(5.5) million.
  - Period: first quarter ended March 31, 2026
  - Revenue: $2,015,225
  - Net income: $(5.5) million
  - Result: reported results
  source text: announced financial results for the first quarter ended March 31, 2026. Q1 2026 Financial Highlights (all metrics compared to Q1 2025 unless otherwise noted) ● Revenue was $2,015,225, an increase of 23% compared to $1,637,185. ● Consolidated clinic revenue increased 22% to $1,982,233, compared to $1,621,553. ● Net loss from continuing operations was $(5.5)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315226029517/0001493152-26-029517-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.